The emerging approach of this peptide represents a exciting development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide impacts dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide173659.tokka-blog.com/42449180/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment